VLA-4 antagonists

Details for Australian Patent Application No. 2005277634 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Munoz, Benito; Wang, Bowei; Chen, Weichao; Venkatraman, Shankar; Lebsack, Alec D.

Agent Spruson & Ferguson

Pub. Number AU-B-2005277634

PCT Pub. Number WO2006/023396

Priority 60/601,942 16.08.04 US

Filing date 12 August 2005

Wipo publication date 2 March 2006

Acceptance publication date 17 February 2011

International Classifications

C07K 5/078 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/05 (2006.01) Medicinal preparations containing peptides - Dipeptides

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

15 March 2007 PCT application entered the National Phase

  PCT publication WO2006/023396 Priority application(s): WO2006/023396

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

17 February 2011 Application Accepted

  Published as AU-B-2005277634

16 June 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005277637-Methods and apparatuses for producing alternatively shaped confectionary products

2005277627-Shirred casing